CN110692741A - Formula milk powder for promoting bone growth and preparation method thereof - Google Patents
Formula milk powder for promoting bone growth and preparation method thereof Download PDFInfo
- Publication number
- CN110692741A CN110692741A CN201911101825.1A CN201911101825A CN110692741A CN 110692741 A CN110692741 A CN 110692741A CN 201911101825 A CN201911101825 A CN 201911101825A CN 110692741 A CN110692741 A CN 110692741A
- Authority
- CN
- China
- Prior art keywords
- parts
- powder
- milk
- milk powder
- compound nutrient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 title claims abstract description 95
- 235000013350 formula milk Nutrition 0.000 title claims abstract description 36
- 230000001737 promoting effect Effects 0.000 title claims abstract description 17
- 230000008468 bone growth Effects 0.000 title claims abstract description 16
- 238000002360 preparation method Methods 0.000 title abstract description 8
- 235000013336 milk Nutrition 0.000 claims abstract description 43
- 239000008267 milk Substances 0.000 claims abstract description 43
- 210000004080 milk Anatomy 0.000 claims abstract description 43
- 235000015097 nutrients Nutrition 0.000 claims abstract description 31
- 150000001875 compounds Chemical class 0.000 claims abstract description 27
- 239000006041 probiotic Substances 0.000 claims abstract description 22
- 235000018291 probiotics Nutrition 0.000 claims abstract description 22
- 102000014171 Milk Proteins Human genes 0.000 claims abstract description 17
- 108010011756 Milk Proteins Proteins 0.000 claims abstract description 17
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 17
- 235000021239 milk protein Nutrition 0.000 claims abstract description 17
- 239000011707 mineral Substances 0.000 claims abstract description 17
- 150000003839 salts Chemical class 0.000 claims abstract description 17
- 108010046377 Whey Proteins Proteins 0.000 claims abstract description 15
- 102000007544 Whey Proteins Human genes 0.000 claims abstract description 15
- 229920001542 oligosaccharide Polymers 0.000 claims abstract description 15
- 150000002482 oligosaccharides Chemical class 0.000 claims abstract description 15
- 239000005862 Whey Substances 0.000 claims abstract description 14
- 230000000529 probiotic effect Effects 0.000 claims abstract description 14
- 235000020183 skimmed milk Nutrition 0.000 claims abstract description 12
- 235000008939 whole milk Nutrition 0.000 claims abstract description 12
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims abstract description 11
- 239000008101 lactose Substances 0.000 claims abstract description 11
- 239000002994 raw material Substances 0.000 claims abstract description 10
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims abstract description 8
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims abstract description 8
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 claims abstract description 8
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 claims abstract description 8
- 239000000787 lecithin Substances 0.000 claims abstract description 8
- 229940067606 lecithin Drugs 0.000 claims abstract description 8
- 235000010445 lecithin Nutrition 0.000 claims abstract description 8
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 8
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 claims abstract description 7
- 240000001046 Lactobacillus acidophilus Species 0.000 claims abstract description 7
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims abstract description 7
- 229940009289 bifidobacterium lactis Drugs 0.000 claims abstract description 7
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims abstract description 7
- 235000013325 dietary fiber Nutrition 0.000 claims abstract description 6
- 229930003231 vitamin Natural products 0.000 claims abstract description 5
- 239000011782 vitamin Substances 0.000 claims abstract description 5
- 229940088594 vitamin Drugs 0.000 claims abstract description 5
- 235000013343 vitamin Nutrition 0.000 claims abstract description 5
- 240000001929 Lactobacillus brevis Species 0.000 claims abstract description 4
- 235000013957 Lactobacillus brevis Nutrition 0.000 claims abstract description 4
- 241000186840 Lactobacillus fermentum Species 0.000 claims abstract description 4
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 claims abstract description 4
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims abstract description 4
- 229940114079 arachidonic acid Drugs 0.000 claims abstract description 4
- 235000021342 arachidonic acid Nutrition 0.000 claims abstract description 4
- 150000001746 carotenes Chemical class 0.000 claims abstract description 4
- 235000005473 carotenes Nutrition 0.000 claims abstract description 4
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims abstract description 4
- 229960001231 choline Drugs 0.000 claims abstract description 4
- 229940090949 docosahexaenoic acid Drugs 0.000 claims abstract description 4
- 235000020669 docosahexaenoic acid Nutrition 0.000 claims abstract description 4
- 229940012969 lactobacillus fermentum Drugs 0.000 claims abstract description 4
- 235000012680 lutein Nutrition 0.000 claims abstract description 4
- 229960005375 lutein Drugs 0.000 claims abstract description 4
- 239000001656 lutein Substances 0.000 claims abstract description 4
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 claims abstract description 4
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 claims abstract description 4
- 229960003512 nicotinic acid Drugs 0.000 claims abstract description 4
- 235000001968 nicotinic acid Nutrition 0.000 claims abstract description 4
- 239000011664 nicotinic acid Substances 0.000 claims abstract description 4
- 239000002773 nucleotide Substances 0.000 claims abstract description 4
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 4
- 229960003080 taurine Drugs 0.000 claims abstract description 4
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 claims abstract description 4
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 claims abstract description 4
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 claims abstract description 4
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 claims abstract description 4
- 229960001763 zinc sulfate Drugs 0.000 claims abstract description 4
- 229910000368 zinc sulfate Inorganic materials 0.000 claims abstract description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 12
- 239000005018 casein Substances 0.000 claims description 9
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 9
- 235000021240 caseins Nutrition 0.000 claims description 9
- 239000000243 solution Substances 0.000 claims description 7
- 229930003427 Vitamin E Natural products 0.000 claims description 6
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 6
- 230000003301 hydrolyzing effect Effects 0.000 claims description 6
- 239000011259 mixed solution Substances 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 235000019165 vitamin E Nutrition 0.000 claims description 6
- 229940046009 vitamin E Drugs 0.000 claims description 6
- 239000011709 vitamin E Substances 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 102000004190 Enzymes Human genes 0.000 claims description 3
- 108090000790 Enzymes Proteins 0.000 claims description 3
- 229930003316 Vitamin D Natural products 0.000 claims description 3
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims description 3
- 229940107187 fructooligosaccharide Drugs 0.000 claims description 3
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 claims description 3
- 239000002068 microbial inoculum Substances 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- -1 serine phospholipid Chemical class 0.000 claims description 3
- 238000001694 spray drying Methods 0.000 claims description 3
- 239000011715 vitamin B12 Substances 0.000 claims description 3
- 239000011716 vitamin B2 Substances 0.000 claims description 3
- 239000011726 vitamin B6 Substances 0.000 claims description 3
- 235000019166 vitamin D Nutrition 0.000 claims description 3
- 239000011710 vitamin D Substances 0.000 claims description 3
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 3
- 229940046008 vitamin d Drugs 0.000 claims description 3
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 3
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 claims description 2
- RQFQJYYMBWVMQG-IXDPLRRUSA-N chitotriose Chemical compound O[C@@H]1[C@@H](N)[C@H](O)O[C@H](CO)[C@H]1O[C@H]1[C@H](N)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)[C@@H](CO)O1 RQFQJYYMBWVMQG-IXDPLRRUSA-N 0.000 claims description 2
- 235000021255 galacto-oligosaccharides Nutrition 0.000 claims description 2
- 150000003271 galactooligosaccharides Chemical class 0.000 claims description 2
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 claims description 2
- 230000001954 sterilising effect Effects 0.000 claims description 2
- 238000004659 sterilization and disinfection Methods 0.000 claims description 2
- 238000000034 method Methods 0.000 claims 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract description 20
- 239000011575 calcium Substances 0.000 abstract description 20
- 229910052791 calcium Inorganic materials 0.000 abstract description 20
- 238000010521 absorption reaction Methods 0.000 abstract description 11
- 239000000126 substance Substances 0.000 abstract description 5
- 241000894006 Bacteria Species 0.000 abstract description 2
- 150000002632 lipids Chemical class 0.000 abstract description 2
- 230000004060 metabolic process Effects 0.000 abstract description 2
- 244000052769 pathogen Species 0.000 abstract description 2
- 235000020256 human milk Nutrition 0.000 description 6
- 210000004251 human milk Anatomy 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 210000001035 gastrointestinal tract Anatomy 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 230000012010 growth Effects 0.000 description 4
- 210000000936 intestine Anatomy 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 239000000022 bacteriostatic agent Substances 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 241000186000 Bifidobacterium Species 0.000 description 1
- 206010007027 Calculus urinary Diseases 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 208000000913 Kidney Calculi Diseases 0.000 description 1
- 206010029148 Nephrolithiasis Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 208000009911 Urinary Calculi Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- 229940069978 calcium supplement Drugs 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 235000020247 cow milk Nutrition 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 238000009928 pasteurization Methods 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 235000020185 raw untreated milk Nutrition 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 150000004666 short chain fatty acids Chemical class 0.000 description 1
- 235000021391 short chain fatty acids Nutrition 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 235000021119 whey protein Nutrition 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C21/00—Whey; Whey preparations
- A23C21/06—Mixtures of whey with milk products or milk components
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C21/00—Whey; Whey preparations
- A23C21/02—Whey; Whey preparations containing, or treated with, microorganisms or enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C21/00—Whey; Whey preparations
- A23C21/08—Whey; Whey preparations containing other organic additives, e.g. vegetable or animal products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C21/00—Whey; Whey preparations
- A23C21/10—Whey; Whey preparations containing inorganic additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/113—Acidophilus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/121—Brevis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/143—Fermentum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/531—Lactis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention discloses a formula milk powder for promoting bone growth and a preparation method thereof, wherein the components comprise whole milk powder, skim milk powder, whey powder, lactose, milk mineral salt, compound nutrient A, compound nutrient B, oligosaccharide and active probiotic freeze-dried powder; the compound nutrient A contains serine phosphatide, lecithin, taurine, dietary fiber and hydrolyzed milk protein; the compound nutrient B comprises docosahexaenoic acid, arachidonic acid, various vitamins, nicotinic acid, zinc sulfate, lutein, carotene, choline, lecithin and nucleotide, and is prepared from active probiotic freeze-dried powder prepared from mixed bacteria of bifidobacterium lactis, lactobacillus acidophilus, lactobacillus fermentum and lactobacillus brevis as raw materials. The invention can effectively improve the absorption of the infant to calcium in the milk powder, balance the absorption of various nutrient substances, improve the resistance of the organism to pathogens, promote the metabolism of lipid and the like.
Description
Technical Field
The invention relates to infant formula milk powder in the technical field of dairy products, in particular to formula milk powder for promoting bone growth and a preparation method thereof.
Background
The infant formula milk powder is prepared by mixing milk, a milk source, a large amount of bacteriostatic substances, protein, lactose and other components which have important promotion effects on the development of infants, wherein the milk source is breast milk, the nutrition is rich, the bacteriostatic substances are abundant, the nutrition cost in the breast milk is easy to absorb, the proportion is reasonable, the components have the important promotion effects on the development of the infants, the components have no damage or adverse effects on organs such as intestines, stomach and kidney which are tender to the infants, the condition that the breast milk is insufficient or the breast milk cannot be fed due to other reasons is always existed in reality, and only the infant formula milk powder can be selected.
In the formula milk powder, the important nutrient substance is calcium, the calcium required by the growth of infants can only be obtained from the formula milk powder, the milk serving as a common milk source in the formula milk powder is generally accepted as a rich source of calcium, the existing form of the milk is extremely similar to that of calcium in breast milk, the milk is internationally accepted as a calcium source with the best digestive absorption and nutritive value and is also the most suitable calcium source for the delicate intestines and stomachs of babies, but the formula milk powder usually needs to be added with the calcium to make up the defect of low calcium absorption rate in the milk, about 70 percent of the calcium in the common milk in the formula milk powder is in a casein colloidal particle state, and the calcium and artificially synthesized inorganic calcium are easy to form colloidal deposits in an intestinal alkaline environment, have the disadvantages of stimulation to the stomach, difficult absorption by the intestines and stomachs of the babies and the like, so that the health food and the infant formula milk powder which take calcium carbonate as the main calcium source in the market are used in a large amount, the infant formula milk powder not only can increase the burden of the kidney of an infant, but also can deposit a large amount of the infant formula milk powder to form calculus of the urinary system such as kidney calculus and urinary calculus, which is very unfavorable for the growth of the infant, and if phosphate such as calcium hydrogen phosphate is additionally added to adjust the proportion of calcium and phosphorus, the phosphate can influence the absorption of nutrient substances such as iron and zinc, and meanwhile, the problem that substances for immune function, resistance, development of nerves and retina and metabolism of lipid are insufficient in the formula milk powder taking raw milk as a main raw material in the prior art is solved.
Therefore, the trend of researching the calcium supplement raw material of the infant formula milk powder is to find a safe and easily-absorbed calcium source which is suitable for infants and is close to the mother emulsion and add the calcium source into the milk powder.
Disclosure of Invention
The technical problem to be solved by the invention is to provide a formula milk powder for promoting bone growth and a preparation method thereof, so as to solve the defects in the technical background.
The technical problem solved by the invention is realized by adopting the following technical scheme:
the formula milk powder for promoting bone growth specifically comprises the following raw materials in parts by mass:
100 ~ 120 parts of full cream milk powder, 30 ~ 50 parts of skim milk powder, 20 ~ 25 parts of whey powder, 20 ~ 30 parts of lactose, 10 ~ 20 parts of milk mineral salt, 8 ~ 10 parts of compound nutrient A, 1 ~ 3 parts of compound nutrient B, 2 ~ 6 parts of oligosaccharide and active probiotic freeze-dried powder;
wherein the compound nutrient A contains 14 ~ 20% serine phospholipid, 6 ~ 8% lecithin, 3 ~ 5% taurine, dietary fiber 5 ~ 8% and the balance of hydrolyzed milk protein;
the compound nutrient B comprises the following components in parts by mass: docosahexaenoic acid 400 parts, arachidonic acid 11 parts, vitamin A15 parts, vitamin B26 portions of vitamin B612 portions of vitamin B124 parts of vitamin D, 8 parts of vitamin E, 12 parts of vitamin E, 5 parts of nicotinic acid, 3 parts of zinc sulfate, 11 parts of lutein, 12 parts of carotene, 25 parts of choline, 40 parts of lecithin and 32 parts of nucleotide;
the oligosaccharide is a mixture of isomaltooligosaccharide, fructo-oligosaccharide, galacto-oligosaccharide, chitosan oligosaccharide and stachyose in any proportion.
The probiotics in the active probiotic freeze-dried powder are mixed microbial inoculum of bifidobacterium lactis, lactobacillus acidophilus, lactobacillus fermentum and lactobacillus brevis, wherein the proportion of the bifidobacterium lactis to the lactobacillus acidophilus is not less than 30%, and the addition amount of the active probiotic freeze-dried powder is 1 × 107 cfu/g-1 × 108 cfu/g.
As a further limitation, the whey powder is preferably a desalted whey powder.
As a further limitation, the milk mineral salt is a milk mineral salt isolated from milk.
As a further limitation, the hydrolyzed milk protein is preferably a casein-derived hydrolyzed milk protein obtained by completely hydrolyzing casein in milk protein by a hydrolase.
A preparation method of formula milk powder for promoting bone growth comprises the following specific preparation steps:
s1, stirring the raw materials of the full-cream milk powder, the skim milk powder, the whey powder, the lactose, the milk mineral salt and the compound nutrient B in parts by mass in a water bath kettle at 40 ~ 50 ℃ at a constant temperature until the raw materials are completely dissolved, adding the compound nutrient A and the oligosaccharide, continuously stirring until the compound nutrient A and the oligosaccharide are dissolved, and keeping the mixture for 12 ~ 36 hours.
S2, storing the mixed solution prepared in the S1 step in a low-temperature environment at 3 ~ 8 ℃ for 4 ~ 8 h.
S3, drying the mixed solution prepared in the step S2 to enable the water content of the solution to be below 20%, then extracting the solution at the temperature of 40 ~ 50 ℃ by using an extractor, filtering the extract by using a micron filter to 100 meshes, concentrating and spray-drying the extract after sterilization to prepare powdery formula milk powder base powder, then adding active probiotic freeze-dried powder into the formula milk powder base powder, and mixing uniformly to obtain the finished milk powder.
Has the advantages that: the formula milk powder for promoting bone growth has the advantages of easy absorption and comprehensive nutritional ingredients, and can effectively improve the absorption of calcium in the milk powder by infants by utilizing the proportion of the hydrolyzed milk protein to be matched with the whole milk powder and the skim milk powder and the probiotics, and improve the calcium content by utilizing the milk mineral salt; meanwhile, the formula milk powder can also effectively improve the working efficiency of the intestinal tract of the infant, simulates the absorption state of breast milk in the intestinal tract of the infant, has good safety and high absorption and utilization rate, has positive effect on the immune system of the infant, and can improve the resistance of the organism to pathogens.
Detailed Description
In order to make the technical means, the creation characteristics, the achievement purposes and the effects of the invention easy to understand, the invention is further described with the specific embodiments.
In the examples, the formula for promoting bone growth comprises the following raw materials:
whole milk powder: 1100g, skim milk powder: 400g, desalted whey powder: 220g, lactose: 200g, cow milk mineral salt: 120g, compound nutrient A: 90g, compound nutrient B: 30g, oligosaccharide: 40g and active probiotic freeze-dried powder. Wherein the compound nutrient A contains serine phospholipid 16% and lecithin 8%Fat, 3% of taurine, 7% of dietary fiber and 39% of hydrolyzed milk protein, wherein the hydrolyzed milk protein is casein-derived hydrolyzed milk protein obtained by completely hydrolyzing casein through hydrolase; the compound nutrient B comprises the following components in parts by mass: docosahexaenoic acid 400 parts, arachidonic acid 11 parts, vitamin A15 parts, vitamin B26 portions of vitamin B612 portions of vitamin B124 parts of vitamin D, 8 parts of vitamin E, 12 parts of vitamin E, 5 parts of nicotinic acid, 3 parts of zinc sulfate, 11 parts of lutein, 12 parts of carotene, 25 parts of choline, 40 parts of lecithin and 32 parts of nucleotide; wherein the sum of the mass of each component is 30 g.
The oligosaccharide is a mixture of isomaltooligosaccharide, fructooligosaccharide and oligochitosan in a mass ratio of 1:1: 1; the probiotics in the active probiotic freeze-dried powder are mixed microbial inoculum of bifidobacterium lactis, lactobacillus acidophilus, lactobacillus fermentum and lactobacillus brevis, wherein the proportion of the bifidobacterium lactis is 18 percent and the proportion of the lactobacillus acidophilus is 22 percent, and the adding amount of the active probiotic freeze-dried powder in the raw materials is 1 multiplied by 107cfu/g to 1 multiplied by 108 cfu/g; the milk mineral salt is obtained by separating milk from milk.
In the embodiment, the ratio of the hydrolyzed milk protein is matched with the whole milk powder and the skim milk powder, and the probiotics are matched, so that the absorption of calcium in the milk powder by the infant can be effectively improved, and the calcium amount is improved by using milk mineral salt.
And generally think, have got the multiple active peptide with physiological function from different milk protein degradation products, not merely improved the processability of milk protein, and laid the foundation for the deep processing of milk, and casein is hydrolyzed the biological active peptide in the milk protein of casein source hydrolysis obtained after the hydrolytic enzyme is completely hydrolyzed through the hydrolytic enzyme has very important and extensive biological function, can improve the quality of the stomach effectively, increase the ratio of villus height of duodenum and depth of crypt; meanwhile, the whey protein in the raw materials is also pretreated by the probiotics, and the treated product has the functions of improving the cardiovascular system function, improving the immunity and improving the physique, and can effectively adjust the intestinal flora, the immunoregulation activity, the antioxidant function, the antiviral function, the gene regulation function and the like, so that the immunity of the infants can be effectively improved.
The oligosaccharide can be utilized by probiotics in the intestinal tract to proliferate bifidobacterium, so as to inhibit the growth of putrefying bacteria in the intestinal tract and reduce the formation of toxic fermentation products, meanwhile, when the probiotics grow, reproduce and move in the digestive tract, the oligosaccharide can be converted to form or directly generate a plurality of nutrient substances such as vitamins, amino acids, short-chain fatty acids, growth promoting factors and the like, and the oligosaccharide can enhance the immune function by being matched with soluble dietary fibers in the dietary fibers, thereby being beneficial to the digestive system of infants.
In an embodiment, the preparation method of the formula milk powder for promoting bone growth comprises the specific steps of stirring the whole milk powder, the skim milk powder, the whey powder, the lactose, the milk mineral salt and the compound nutrient B in parts by mass in a water bath kettle at 46 ℃ until the whole milk powder, the skim milk powder, the whey powder, the lactose, the milk mineral salt and the compound nutrient B are completely dissolved, adding the compound nutrient A and the oligosaccharide, continuously stirring until the whole milk powder, the skim milk powder, the whey powder, the lactose, the milk mineral salt and the compound nutrient B are dissolved for 24 hours, then keeping the mixture in a low-temperature environment of 4 ~ 5 ℃ for 6 hours, then drying the mixed solution after the mixed solution is stored in the low-temperature environment for 6 hours until the water content of the solution is below 20%, extracting the extracted solution at the temperature of 40 ~ 50 ℃ by using an extractor, filtering the extracted solution to 100 meshes, performing pasteurization, concentrating and spray drying to prepare the powdery formula milk powder base powder, then adding the active probiotic freeze-dried powder into the formula milk powder.
The foregoing shows and describes the general principles, essential features, and advantages of the invention. It will be understood by those skilled in the art that the present invention is not limited to the embodiments described above, which are described in the specification and illustrated only to illustrate the principle of the present invention, but that various changes and modifications may be made therein without departing from the spirit and scope of the present invention, which fall within the scope of the invention as claimed. The scope of the invention is defined by the appended claims and equivalents thereof.
Claims (5)
1. The formula milk powder for promoting bone growth is characterized by specifically comprising the following raw materials in parts by mass:
100 ~ 120 parts of full cream milk powder, 30 ~ 50 parts of skim milk powder, 20 ~ 25 parts of whey powder, 20 ~ 30 parts of lactose, 10 ~ 20 parts of milk mineral salt, 8 ~ 10 parts of compound nutrient A, 1 ~ 3 parts of compound nutrient B, 2 ~ 6 parts of oligosaccharide and active probiotic freeze-dried powder;
wherein the compound nutrient A contains 14 ~ 20% serine phospholipid, 6 ~ 8% lecithin, 3 ~ 5% taurine, dietary fiber 5 ~ 8% and the balance of hydrolyzed milk protein;
the compound nutrient B comprises the following components in parts by mass: docosahexaenoic acid 400 parts, arachidonic acid 11 parts, vitamin A15 parts, vitamin B26 portions of vitamin B612 portions of vitamin B124 parts of vitamin D, 8 parts of vitamin E, 12 parts of vitamin E, 5 parts of nicotinic acid, 3 parts of zinc sulfate, 11 parts of lutein, 12 parts of carotene, 25 parts of choline, 40 parts of lecithin and 32 parts of nucleotide;
the oligosaccharide is a mixture of isomaltooligosaccharide, fructo-oligosaccharide, galacto-oligosaccharide, chitosan oligosaccharide and stachyose in any proportion;
the probiotics in the active probiotic freeze-dried powder are mixed microbial inoculum of bifidobacterium lactis, lactobacillus acidophilus, lactobacillus fermentum and lactobacillus brevis, wherein the proportion of the bifidobacterium lactis to the lactobacillus acidophilus is not less than 30%, and the addition amount of the active probiotic freeze-dried powder is 1 × 107 cfu/g-1 × 108 cfu/g.
2. The bone growth promoting formula of claim 1, wherein said whey powder is a desalted whey powder.
3. The bone growth promoting formula of claim 1, wherein the milk mineral salt is a milk mineral salt isolated from milk.
4. The formula for promoting bone growth according to claim 1, wherein the hydrolyzed milk protein is a casein-derived hydrolyzed milk protein obtained by completely hydrolyzing casein in milk protein by a hydrolytic enzyme.
5. A method for preparing a formula milk powder for promoting bone growth, which is characterized in that the formula milk powder for promoting bone growth in claim 1 is prepared by the following steps:
s1, stirring the whole milk powder, the skim milk powder, the whey powder, the lactose, the milk mineral salt and the compound nutrient B in parts by mass in a water bath kettle at 40 ~ 50 ℃ until the whole milk powder, the skim milk powder, the whey powder, the lactose, the milk mineral salt and the compound nutrient B are completely dissolved, adding the compound nutrient A and the oligosaccharide, continuously stirring until the compound nutrient A and the oligosaccharide are dissolved, and keeping the mixture for 12 ~ 36 hours;
s2, storing the mixed solution prepared in the S1 step in a low-temperature environment at the temperature of 3 ~ 8 ℃ for 4 ~ 8 h;
s3, drying the mixed solution prepared in the step S2 to enable the water content of the solution to be below 20%, then extracting the solution at the temperature of 40 ~ 50 ℃ by using an extractor, filtering the extract by using a micron filter to 100 meshes, concentrating and spray-drying the extract after sterilization to prepare powdery formula milk powder base powder, then adding active probiotic freeze-dried powder into the formula milk powder base powder, and mixing uniformly to obtain the finished milk powder.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911101825.1A CN110692741A (en) | 2019-11-12 | 2019-11-12 | Formula milk powder for promoting bone growth and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911101825.1A CN110692741A (en) | 2019-11-12 | 2019-11-12 | Formula milk powder for promoting bone growth and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110692741A true CN110692741A (en) | 2020-01-17 |
Family
ID=69205045
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911101825.1A Pending CN110692741A (en) | 2019-11-12 | 2019-11-12 | Formula milk powder for promoting bone growth and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110692741A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111657354A (en) * | 2020-06-28 | 2020-09-15 | 广东亨盛维嘉食品工业有限公司 | Composite probiotic lactase modified milk powder capable of keeping activity for long time |
CN113068746A (en) * | 2020-03-26 | 2021-07-06 | 魏利成 | Formula of medicine-food homologous milk powder capable of promoting bone growth |
CN115644256A (en) * | 2022-11-10 | 2023-01-31 | 内蒙古伊利实业集团股份有限公司 | Composition and modified milk powder beneficial to eyesight health as well as preparation method and application of modified milk powder |
CN116649420A (en) * | 2023-06-05 | 2023-08-29 | 高培(广州)乳业有限公司 | Nutritional milk powder with effects of nourishing intelligence and promoting digestion and absorption, and its preparation method |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102038041A (en) * | 2010-11-17 | 2011-05-04 | 许德建 | Mineral substance formula milk powder for infants |
CN102187913A (en) * | 2011-07-04 | 2011-09-21 | 澳优乳业(中国)有限公司 | Organic formula milk powder for babies and infants and method for preparing same |
CN103371235A (en) * | 2012-04-24 | 2013-10-30 | 浙江康恩贝健康产品有限公司 | Infant formula milk powder and preparation method thereof |
CN104026251A (en) * | 2014-05-30 | 2014-09-10 | 江西美庐乳业集团有限公司 | Infant formula milk powder and preparation method thereof |
CN104982533A (en) * | 2015-07-17 | 2015-10-21 | 多加多乳业(天津)有限公司 | Formula milk powder for enhancing immunity of infants and preparation method |
CN105360319A (en) * | 2015-10-10 | 2016-03-02 | 石家庄君乐宝乳业有限公司 | Child development formula milk powder and preparation method thereof |
CN105724584A (en) * | 2016-03-14 | 2016-07-06 | 上海晨冠乳业有限公司 | Infant formula milk powder with prebiotics and probiotics and method for preparing infant formula milk powder |
CN105746728A (en) * | 2016-03-14 | 2016-07-13 | 上海晨冠乳业有限公司 | Infant formula milk powder simulating breast milk and preparation method of infant formula milk powder |
CN108029768A (en) * | 2017-11-29 | 2018-05-15 | 上海晨冠乳业有限公司 | A kind of baby formula milk powder containing lactoferrin and probiotics and preparation method thereof |
CN108157512A (en) * | 2018-02-05 | 2018-06-15 | 高培(广州)乳业有限公司 | A kind of formula milk for strengthening 6 ~ 12 months infant's gastrointestinal functions |
CN109845827A (en) * | 2019-01-25 | 2019-06-07 | 上海花冠营养乳品有限公司 | A kind of infant milk powder for simulating breast-feeding infant intestinal microecology |
-
2019
- 2019-11-12 CN CN201911101825.1A patent/CN110692741A/en active Pending
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102038041A (en) * | 2010-11-17 | 2011-05-04 | 许德建 | Mineral substance formula milk powder for infants |
CN102187913A (en) * | 2011-07-04 | 2011-09-21 | 澳优乳业(中国)有限公司 | Organic formula milk powder for babies and infants and method for preparing same |
CN103371235A (en) * | 2012-04-24 | 2013-10-30 | 浙江康恩贝健康产品有限公司 | Infant formula milk powder and preparation method thereof |
CN104026251A (en) * | 2014-05-30 | 2014-09-10 | 江西美庐乳业集团有限公司 | Infant formula milk powder and preparation method thereof |
CN104982533A (en) * | 2015-07-17 | 2015-10-21 | 多加多乳业(天津)有限公司 | Formula milk powder for enhancing immunity of infants and preparation method |
CN105360319A (en) * | 2015-10-10 | 2016-03-02 | 石家庄君乐宝乳业有限公司 | Child development formula milk powder and preparation method thereof |
CN105724584A (en) * | 2016-03-14 | 2016-07-06 | 上海晨冠乳业有限公司 | Infant formula milk powder with prebiotics and probiotics and method for preparing infant formula milk powder |
CN105746728A (en) * | 2016-03-14 | 2016-07-13 | 上海晨冠乳业有限公司 | Infant formula milk powder simulating breast milk and preparation method of infant formula milk powder |
CN108029768A (en) * | 2017-11-29 | 2018-05-15 | 上海晨冠乳业有限公司 | A kind of baby formula milk powder containing lactoferrin and probiotics and preparation method thereof |
CN108157512A (en) * | 2018-02-05 | 2018-06-15 | 高培(广州)乳业有限公司 | A kind of formula milk for strengthening 6 ~ 12 months infant's gastrointestinal functions |
CN109845827A (en) * | 2019-01-25 | 2019-06-07 | 上海花冠营养乳品有限公司 | A kind of infant milk powder for simulating breast-feeding infant intestinal microecology |
Non-Patent Citations (2)
Title |
---|
尹桂山等: "酶水解法调整牛乳中清蛋白与酪蛋白的比例提高乳粉营养价值的研究", 《河北省科学院学报》 * |
生庆海等: "酶水解法生产婴幼儿配方奶粉新技术研究进展", 《中国乳品工业》 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113068746A (en) * | 2020-03-26 | 2021-07-06 | 魏利成 | Formula of medicine-food homologous milk powder capable of promoting bone growth |
CN111657354A (en) * | 2020-06-28 | 2020-09-15 | 广东亨盛维嘉食品工业有限公司 | Composite probiotic lactase modified milk powder capable of keeping activity for long time |
CN115644256A (en) * | 2022-11-10 | 2023-01-31 | 内蒙古伊利实业集团股份有限公司 | Composition and modified milk powder beneficial to eyesight health as well as preparation method and application of modified milk powder |
CN116649420A (en) * | 2023-06-05 | 2023-08-29 | 高培(广州)乳业有限公司 | Nutritional milk powder with effects of nourishing intelligence and promoting digestion and absorption, and its preparation method |
CN116649420B (en) * | 2023-06-05 | 2024-05-24 | 高培(广州)乳业有限公司 | Nutritional milk powder with effects of nourishing intelligence and promoting digestion and absorption, and its preparation method |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110692741A (en) | Formula milk powder for promoting bone growth and preparation method thereof | |
CN102551043B (en) | Oyster polypeptide nutrition supplement food for children and preparation method thereof | |
Kalavathy et al. | Effects of Lactobacillus cultures on growth performance, abdominal fat deposition, serum lipids and weight of organs of broiler chickens | |
CN103564044B (en) | A kind of Yoghourt containing marine alga and preparation method thereof | |
TW200911278A (en) | Reduction of risk of diarrhoea | |
CN104256595A (en) | Intacted protein enteral nutrition multi-polymerization agent | |
CN101240255A (en) | Method for preparing probiotics leaven used for plant-derived albumen | |
CN103583692A (en) | Symbiotic functional high-protein Greek yogurt utilizing polymeric whey protein as main thickening agent and preparation method thereof | |
CN103271274B (en) | Nutrient health-care porridge | |
CN104982533A (en) | Formula milk powder for enhancing immunity of infants and preparation method | |
CN112244095A (en) | Milk powder for regulating immunity and preparation method thereof | |
CN112998080A (en) | Infant formula milk powder added with yolk phospholipid, soybean phospholipid and milk phospholipid | |
CN112075504A (en) | Infant formula milk powder for enhancing immunity | |
CN107347998A (en) | A kind of baby milk powder for strengthening nutrient absorption and immunity of organisms and preparation method thereof | |
CN105076417A (en) | Intestine protective formula milk powder and preparation method thereof | |
CN112167348A (en) | Formula milk powder for promoting growth and development of children and preparation method thereof | |
CN100334226C (en) | Process and application for producing fermant protein peptide | |
CN105076418A (en) | Infant formula milk powder for promoting development of brain nerves and gastrointestinal tissues of infants | |
RU2703177C2 (en) | Infant nutrition with hydrolysed protein, ionic calcium and palmitic acid | |
CN106819472A (en) | One boar biological feedstuff and preparation method thereof, purposes | |
CN107467193B (en) | A powder food based on goat milk for special medical use and its preparation method | |
CN112535217A (en) | Maternal emulsified hypoallergenic fresh and alive infant formula milk and preparation method thereof | |
RU2426438C2 (en) | Synbiotic composition for correction of intestinal tract microbiocenosis abnormalities and enhancement of organism general resistivity and its production methods (versions) | |
CN114190441A (en) | Formula milk powder for promoting growth and development of children and preparation method thereof | |
CN111642566A (en) | Goat milk powder beneficial to children's height and intelligence development |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200117 |